Invention Publication
- Patent Title: ANTI-HEMOJUVELIN (HJV) ANTIBODIES FOR TREATING MYELOFIBROSIS
-
Application No.: US17924672Application Date: 2021-05-13
-
Publication No.: US20230174645A1Publication Date: 2023-06-08
- Inventor: Maria Beconi , John Quisel , Brian MacDonald , Steven Robinette , Bernhard Mueller , Andreas Popp , Jennifer M. Perez
- Applicant: Disc Medicine, Inc. , AbbVie Inc. , AbbVie Deutschland GmbH & Co. KG
- Applicant Address: US MA Watertown
- Assignee: Disc Medicine, Inc.,AbbVie Inc.,AbbVie Deutschland GmbH & Co. KG
- Current Assignee: Disc Medicine, Inc.,AbbVie Inc.,AbbVie Deutschland GmbH & Co. KG
- Current Assignee Address: US MA Watertown; US IL North Chicago; DE Wiesbaden
- International Application: PCT/US2021/032343 2021.05.13
- Date entered country: 2022-11-10
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61P35/00
Abstract:
Aspects of the application provide anti-hemojuvelin antibodies and methods of using the same in treating myelofibrosis and/or conditions associated with myelofibrosis.
Information query
